Related Experiment Videos

Changes in NMDAR2 subunit mRNA levels during pentobarbital tolerance/withdrawal in the rat brain: an in situ

C G Jang1, S Oh, I K Ho

  • 1Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216-4505, USA.

Neurochemical Research
|November 14, 1998
PubMed

Insights

Pentobarbital alters NMDA receptor subunit mRNA levels, impacting tolerance and withdrawal. Specifically, NR2A and NR2C mRNA increased, while NR2B mRNA decreased in rat brains.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The molecular mechanisms underlying NMDA receptor subunit modulation during drug tolerance and withdrawal remain largely unexplored.
  • NMDA receptors are crucial for synaptic plasticity and neuronal excitability.

Purpose of the Study:

  • To investigate the role of NMDA receptor 2 (NR2) subunits (NR2A, NR2B, NR2C) in pentobarbital tolerance and withdrawal.
  • To elucidate the impact of pentobarbital on NR2 subunit mRNA expression in the rat brain.

Main Methods:

  • Animals were rendered tolerant to pentobarbital via continuous intracerebroventricular (i.c.v.) infusion.
  • Pentobarbital dependence was induced, followed by abrupt withdrawal.
  • In situ hybridization histochemistry was used to quantify NR2A, NR2B, and NR2C mRNA levels in specific brain regions.

Main Results:

  • Pentobarbital tolerance and withdrawal significantly altered NR2 subunit mRNA expression.
  • NR2A mRNA levels increased in cortical areas in both tolerant and withdrawal states.
  • NR2B mRNA levels decreased in the parietal cortex and hippocampus, while NR2C mRNA levels increased during withdrawal.

Conclusions:

  • Continuous pentobarbital administration modulates NR2 subunit mRNA expression in the rat brain.
  • These findings suggest that NR2 subunits play a significant role in the development of pentobarbital tolerance and withdrawal symptoms.

Related Concept Videos